tau protein inhibitor

This page covers all tau protein inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting tau protein.

Targets

tau protein

Phase 3 pipeline (1)

• RVT-101 · Axovant Sciences Ltd. · Neurology
  RVT-101 is a small molecule that targets the tau protein to treat neurodegenerative diseases.

Patent intelligence

• tau protein inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates